143 related articles for article (PubMed ID: 2684006)
21. The use of chlorpromazine in the treatment of cholera and other severe acute watery diarrheal diseases.
Islam MR; Sack DA; Holmgren J; Bardhan PK; Rabbani GH
Gastroenterology; 1982 Jun; 82(6):1335-40. PubMed ID: 7040157
[TBL] [Abstract][Full Text] [Related]
22. Rice-ORS versus glucose-ORS in management of severe cholera due to Vibrio cholerae O139 Bengal: a randomized, controlled clinical trial.
Hossain MS; Salam MA; Rabbani GH; Kabir I; Biswas R; Mahalanabis D
J Health Popul Nutr; 2003 Dec; 21(4):325-31. PubMed ID: 15038587
[TBL] [Abstract][Full Text] [Related]
23. Comparative trial of tetracycline, chloramphenicol, and trimethoprim-sulphamethoxazole in eradication of Vibrio cholerae El Tor.
Gharagozloo RA; Naficy K; Mouin M; Nassirzadeh MH; Yalda R
Br Med J; 1970 Oct; 4(5730):281-2. PubMed ID: 4920226
[TBL] [Abstract][Full Text] [Related]
24. A comparison of furazolidone and ampicillin in the treatment of invasive diarrhea.
Prado Camacho JL
Scand J Gastroenterol Suppl; 1989; 169():54-9. PubMed ID: 2694344
[TBL] [Abstract][Full Text] [Related]
25. A Phase 2a randomized, single-center, double-blind, placebo-controlled study to evaluate the safety and preliminary efficacy of oral iOWH032 against cholera diarrhea in a controlled human infection model.
Erdem R; Ambler G; Al-Ibrahim M; Fraczek K; Dong SD; Gast C; Mercer LD; Raine M; Tennant SM; Chen WH; de Hostos EL; Choy RKM
PLoS Negl Trop Dis; 2021 Nov; 15(11):e0009969. PubMed ID: 34793441
[TBL] [Abstract][Full Text] [Related]
26. Furazolidone in the treatment of cholera.
Chaudhuri RN; Neogy KN; Sanyal SN; Gupta RK; Manji P
Lancet; 1968 Feb; 1(7538):332-3. PubMed ID: 4170163
[No Abstract] [Full Text] [Related]
27. A randomized double blind trial of aspirin versus placebo in cholera and non-cholera diarrhoea.
Islam A; Bardhan PK; Islam MR; Rahman M
Trop Geogr Med; 1986 Sep; 38(3):221-5. PubMed ID: 3529538
[TBL] [Abstract][Full Text] [Related]
28. Comparative trial of five antimicrobial compounds in the treatment of cholera in adults.
Khan WA; Begum M; Salam MA; Bardhan PK; Islam MR; Mahalanabis D
Trans R Soc Trop Med Hyg; 1995; 89(1):103-6. PubMed ID: 7747291
[TBL] [Abstract][Full Text] [Related]
29. Single-dose doxycycline for cholera.
Sack DA; Islam S; Rabbani H; Islam A
Antimicrob Agents Chemother; 1978 Sep; 14(3):462-4. PubMed ID: 708024
[TBL] [Abstract][Full Text] [Related]
30. Comparative effectiveness of co-trimoxazole and tetracycline in the treatment of Cholera.
Grados P; Bravo N; Battilana C
Bull Pan Am Health Organ; 1996 Mar; 30(1):36-42. PubMed ID: 8919724
[TBL] [Abstract][Full Text] [Related]
31. Clinical features, antimicrobial susceptibility and toxin production in Vibrio cholerae O139 infection: comparison with V. cholerae O1 infection.
Dhar U; Bennish ML; Khan WA; Seas C; Huq Khan E; Albert MJ; Abdus Salam M
Trans R Soc Trop Med Hyg; 1996; 90(4):402-5. PubMed ID: 8882188
[TBL] [Abstract][Full Text] [Related]
32. Treatment of acute bacterial diarrhea: a multicenter international trial comparing placebo with fleroxacin given as a single dose or once daily for 3 days.
Butler T; Lolekha S; Rasidi C; Kadio A; del Rosal PL; Iskandar H; Rubinstein E; Pastore G
Am J Med; 1993 Mar; 94(3A):187S-194S. PubMed ID: 8452179
[TBL] [Abstract][Full Text] [Related]
33. One-week regimens containing ranitidine bismuth citrate, furazolidone and either amoxicillin or tetracycline effectively eradicate Helicobacter pylori: a multicentre, randomized, double-blind study.
Lu H; Zhang DZ; Hu PJ; Li ZS; Lu XH; Fang XC; Xiao SD
Aliment Pharmacol Ther; 2001 Dec; 15(12):1975-9. PubMed ID: 11736729
[TBL] [Abstract][Full Text] [Related]
34. Cholera: synopsis of clinical aspects and principles of treatment.
Frost WH
Can Med Assoc J; 1976 Sep; 115(5):401-3. PubMed ID: 953914
[TBL] [Abstract][Full Text] [Related]
35. An evaluation of current cholera treatment.
Bhattacharya SK
Expert Opin Pharmacother; 2003 Feb; 4(2):141-6. PubMed ID: 12562304
[TBL] [Abstract][Full Text] [Related]
36. Single dose azithromycin versus ciprofloxacin for cholera in children: a randomized controlled trial.
Kaushik JS; Gupta P; Faridi MM; Das S
Indian Pediatr; 2010 Apr; 47(4):309-15. PubMed ID: 19578229
[TBL] [Abstract][Full Text] [Related]
37. Single-dose azithromycin for the treatment of cholera in adults.
Saha D; Karim MM; Khan WA; Ahmed S; Salam MA; Bennish ML
N Engl J Med; 2006 Jun; 354(23):2452-62. PubMed ID: 16760445
[TBL] [Abstract][Full Text] [Related]
38. Clinical and immunologic characteristics of Vibrio cholerae O139 Bengal infection in North American volunteers.
Morris JG; Losonsky GE; Johnson JA; Tacket CO; Nataro JP; Panigrahi P; Levin MM
J Infect Dis; 1995 Apr; 171(4):903-8. PubMed ID: 7706818
[TBL] [Abstract][Full Text] [Related]
39. Randomized, double-blind, placebo-controlled, multicentered trial of the efficacy of a single dose of live oral cholera vaccine CVD 103-HgR in preventing cholera following challenge with Vibrio cholerae O1 El tor inaba three months after vaccination.
Tacket CO; Cohen MB; Wasserman SS; Losonsky G; Livio S; Kotloff K; Edelman R; Kaper JB; Cryz SJ; Giannella RA; Schiff G; Levine MM
Infect Immun; 1999 Dec; 67(12):6341-5. PubMed ID: 10569747
[TBL] [Abstract][Full Text] [Related]
40. The vaccine candidate Vibrio cholerae 638 is protective against cholera in healthy volunteers.
García L; Jidy MD; García H; Rodríguez BL; Fernández R; Año G; Cedré B; Valmaseda T; Suzarte E; Ramírez M; Pino Y; Campos J; Menéndez J; Valera R; González D; González I; Pérez O; Serrano T; Lastre M; Miralles F; Del Campo J; Maestre JL; Pérez JL; Talavera A; Pérez A; Marrero K; Ledón T; Fando R
Infect Immun; 2005 May; 73(5):3018-24. PubMed ID: 15845509
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
